
Recent Articles
Are Healthcare Stocks Terminally Ill?
Healthcare stocks were rocked hard this week, but they will recover. The news that Amazon, Berkshire Hathaway and JPMorgan are forming their own healthcare company will not hold other healthcare stocks down for the long-term.
Trade of the Day: Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
Teva Pharmaceutical is facing a number of fundamental headwinds as it approaches its quarterly earnings announcement.
Everything You Need to Know About the U.S. Dollar and Davos
The U.S. dollar is dropping again following comments from U.S. Treasury Secretary Steven Mnuchin. This will likely impact the market, but non-currency traders may not know that this doesn’t usually equate to a bad/ good dollar.
Trade of the Day: Devon Energy (DVN)
We plan to trade the Devon Energy (DVN) breakout very carefully, but now that the news is out on some of the larger firms, upside to the $50 range seems likely.
Trade of the Day: Applied Materials (AMAT)
Faster, cheaper memory seems to be an inevitable trend, which bodes well for Applied Materials (AMAT) and stocks in this sector.
After Dow 26,000, Are Investors Walking Into a Trap?
The uptrend in the Dow Jones is accelerating, pushing the index to Dow 26,000. Should investors take money off the table?
Trade of the Day: General Electric Company (GE)
While traders are wondering every day whether the market has reached its peak and is about to sell off, we expect uncertainty at GE to drive the stock lower.
Get Prepped for Earnings Risks
As we roll back into earnings season, there are a few things that could cause companies some problems, so be prepared.
Is It Time to Take Some Money Off the Table?
Will 2018 be the year to take some money off of the table and play it safe just in case the market takes a turn for the worse?
Trade of the Day: Macy’s, Inc. (M)
Industry-wide data show that this part of retail is likely to be the weak spot in this season’s earnings.

Join InvestorPlace Digest — FREE!
Get the best free advice from the world-class analysts at InvestorPlace... delivered straight to your inbox.